Labiana Health (XMAD:LAB) Capex-to-Revenue : 0.00 (As of Dec. 2022)

View and export this data going back to 2022. Start your Free Trial

What is Labiana Health Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Labiana Health's Capital Expenditure for the six months ended in Dec. 2022 was €0.00 Mil. Its Revenue for the six months ended in Dec. 2022 was €28.79 Mil.

Hence, Labiana Health's Capex-to-Revenue for the six months ended in Dec. 2022 was 0.00.

Labiana Health Capex-to-Revenue Historical Data

The historical data trend for Labiana Health's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Labiana Health Capex-to-Revenue Chart

Labiana Health Annual Data

Trend

Dec20

Dec21

Dec22

Capex-to-Revenue

0.12

0.08

0.09

Labiana Health Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22
Capex-to-Revenue	-	-	-	-

Competitive Comparison of Labiana Health's Capex-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Labiana Health's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Labiana Health's Capex-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Labiana Health's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Labiana Health's Capex-to-Revenue falls into.

Labiana Health Capex-to-Revenue Calculation

Labiana Health's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-5.453)	/	57.848
	=	0.09

Labiana Health's Capex-to-Revenue for the quarter that ended in Dec. 2022 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (0)	/	28.787
	=	0.00

Labiana Health (XMAD:LAB) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

Labiana Health Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Labiana Health's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Labiana Health (XMAD:LAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Labiana Health SA (XMAD:LAB) » Definitions » Capex-to-Revenue

Traded in Other Exchanges

N/A

Address

Avenida Europa, 34 1st D, Pozuelo de Alarcon, Madrid, ESP, 28023

Website

https://www.labiana.com

Labiana Health SA is a manufacturer of pharmacological products for veterinary use. The company's activities include GMP manufacturer for EU animal and human health industries, manufacturer specialized in sterile and lyophilized dosage forms, source of development, acquisition, and licensing of molecules such as Fosfomycin Trometamol.